CA2221706A1 - G-protein receptor htnad29 - Google Patents
G-protein receptor htnad29 Download PDFInfo
- Publication number
- CA2221706A1 CA2221706A1 CA002221706A CA2221706A CA2221706A1 CA 2221706 A1 CA2221706 A1 CA 2221706A1 CA 002221706 A CA002221706 A CA 002221706A CA 2221706 A CA2221706 A CA 2221706A CA 2221706 A1 CA2221706 A1 CA 2221706A1
- Authority
- CA
- Canada
- Prior art keywords
- polypeptide
- receptor
- polynucleotide
- dna
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Biotechnology (AREA)
- Cardiology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Physics & Mathematics (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Plant Pathology (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1995/007288 WO1996039442A1 (en) | 1995-06-06 | 1995-06-06 | G-protein receptor htnad29 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2221706A1 true CA2221706A1 (en) | 1996-12-12 |
Family
ID=22249278
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002221706A Abandoned CA2221706A1 (en) | 1995-06-06 | 1995-06-06 | G-protein receptor htnad29 |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0832126A4 (de) |
JP (1) | JPH11506341A (de) |
KR (1) | KR19990022531A (de) |
CN (1) | CN1147505C (de) |
AU (1) | AU714642B2 (de) |
CA (1) | CA2221706A1 (de) |
WO (1) | WO1996039442A1 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6221627B1 (en) | 1997-02-24 | 2001-04-24 | Smithkline Beecham Corporation | cDNA clone HDPB130 that encodes a novel human 7-transmembrane receptor |
US6555339B1 (en) * | 1997-04-14 | 2003-04-29 | Arena Pharmaceuticals, Inc. | Non-endogenous, constitutively activated human protein-coupled receptors |
EP2264068A1 (de) * | 1998-10-13 | 2010-12-22 | Arena Pharmaceuticals, Inc. | Nicht-endogene, konstitutiv aktivierte, menschliche, mit G-Proteinen gekoppelte Rezeptoren |
WO2001009328A1 (en) | 1999-08-03 | 2001-02-08 | Millennium Pharmaceuticals, Inc. | 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof |
US6919176B2 (en) | 2001-05-07 | 2005-07-19 | Amgen Inc. | Polypeptides and nucleic acids associated with cancer |
AU2003206749A1 (en) * | 2002-02-01 | 2003-09-02 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with the gpr65 receptor |
WO2004112823A1 (en) | 2003-06-20 | 2004-12-29 | Novartis Ag | Proton-sensing g-protein coupled receptors and dna sequences thereof |
WO2008101354A1 (en) * | 2007-02-22 | 2008-08-28 | Merck Frosst Canada Ltd | Gpr65 as a therapeutic target in allergic airway inflammation |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5262529A (en) * | 1990-01-24 | 1993-11-16 | President And Fellows Of Harvard College | Diagnosis of hereditary retinal degenerative diseases |
US5462856A (en) * | 1990-07-19 | 1995-10-31 | Bunsen Rush Laboratories, Inc. | Methods for identifying chemicals that act as agonists or antagonists for receptors and other proteins involved in signal transduction via pathways that utilize G-proteins |
DE69232876D1 (de) * | 1991-10-01 | 2003-01-30 | Us Gov Health & Human Serv | Ein verfahren zur identifikation von liganden und ligandantagonisten |
WO1994005695A1 (en) * | 1992-09-10 | 1994-03-17 | New York University | Polypeptides of g-coupled receptor proteins, and compositions and methods thereof |
US6066322A (en) * | 1995-03-03 | 2000-05-23 | Millennium Pharmaceuticals, Inc. | Methods for the treatment of immune disorders |
-
1995
- 1995-06-06 KR KR1019970709012A patent/KR19990022531A/ko not_active Application Discontinuation
- 1995-06-06 CA CA002221706A patent/CA2221706A1/en not_active Abandoned
- 1995-06-06 CN CNB951979256A patent/CN1147505C/zh not_active Expired - Fee Related
- 1995-06-06 WO PCT/US1995/007288 patent/WO1996039442A1/en not_active Application Discontinuation
- 1995-06-06 AU AU28204/95A patent/AU714642B2/en not_active Ceased
- 1995-06-06 EP EP95923763A patent/EP0832126A4/de not_active Withdrawn
- 1995-06-06 JP JP9500379A patent/JPH11506341A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CN1193980A (zh) | 1998-09-23 |
WO1996039442A1 (en) | 1996-12-12 |
KR19990022531A (ko) | 1999-03-25 |
AU714642B2 (en) | 2000-01-06 |
AU2820495A (en) | 1996-12-24 |
CN1147505C (zh) | 2004-04-28 |
EP0832126A4 (de) | 2000-01-12 |
EP0832126A1 (de) | 1998-04-01 |
JPH11506341A (ja) | 1999-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20030023044A1 (en) | Human G-Protein chemokine receptor (CCR5) HDGNR10 | |
EP1369430A2 (de) | Zwei menschliche G-Protein-gekoppelte Rezeptorproteine: EBV-induzierter GPCR (EBI-2) und EGD-1-ählicher GPCR | |
US20080241124A1 (en) | Human G-Protein Chemokine Receptor (CCR5) HDGNR10 | |
US20050214281A1 (en) | G-protein coupled receptor | |
US5861272A (en) | C5A receptor | |
US20050266527A1 (en) | Human G-protein receptor HIBEF51 | |
WO1996039435A1 (en) | Human g-protein receptor hpraj70 | |
US20060148708A1 (en) | C5a receptor | |
AU714642B2 (en) | G-protein receptor HTNAD29 | |
US20020106740A1 (en) | Human G-protein receptor HPRAJ70 | |
US6338951B1 (en) | G-protein parathyroid hormone receptor HLTDG74 | |
EP0955808A1 (de) | Humaner, in g-protein gekoppelter rezeptor | |
EP1146055A2 (de) | Menschlicher G-Protein chemokinrezeptor HDGNR10 (CCR5 Rezeptor) | |
US20050123998A1 (en) | C5a receptor | |
EP1149582A2 (de) | Menschlicher G:Protein chemokinrezeptor HDGNR10 (CCR5 Rezeptor). Seine Verwendungen | |
US20090036398A1 (en) | Human G-Protein Coupled Receptor (HETGQ23) | |
US20050059114A1 (en) | G-protein receptor HTNAD29 | |
US20080312178A1 (en) | Human G-Protein Receptor HGBER32 | |
CA2220978A1 (en) | Human g-protein coupled receptor (hetgq23) | |
AU760468B2 (en) | G-protein receptor HTNAD29 | |
US20050266522A1 (en) | Human amine receptor | |
US20060014243A1 (en) | Human G-protein chemokine receptor HSATU68 | |
US20030054487A1 (en) | Human G-protein coupled receptor | |
US20020106734A1 (en) | Adrenergic receptor | |
CA2221116A1 (en) | G-protein parathyroid hormone receptor hltdg74 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |